Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-08-07

FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bisoprolol Fumarate by Unichem Pharmaceuticals (USA), Inc., resulting in a labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol Fumarate (bisoprolol fumarate)

Snippet

SUPPL AP for BISOPROLOL FUMARATE (BISOPROLOL FUMARATE)